Search

everythinglearnresearchcommunity

for

Search:↓

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

PPARα agonists may help treat alopecia areata by reducing inflammation.

STAT5 is crucial for hair growth in 3D cultured human dermal papilla cells.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Melatonin affects certain genes and pathways involved in cashmere goat hair growth.

Melatonin can increase cashmere yield by altering gene expression and restarting the growth cycle early.

PRC1 influences skin stem cell development by both turning genes on and off, affecting hair growth and skin cell types.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

The hair follicle dermal sheath is essential for hair shedding and needs to communicate with the outer root sheath for normal hair growth cycles.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

New treatments for severe alopecia areata show promise but lack standard approval.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Understanding glycans and enzymes that alter them is key to controlling hair growth.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Capparis decidua fruit may help break down blood clots, but more research is needed.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Hair follicles in the back of the rosette fancy mouse have reversed orientations due to a gene mutation.